Skip to Main Content

Paper Details

TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report.
Pediatr Blood Cancer
1
2023
Children, Li-Fraumeni syndrome, RMS, Rhabdomyosarcoma, TP53, TP53 PVs, anRMS, anaplasia, anaplastic rhabdomyosarcoma, cancer, germline, germline TP53 PVs, germline TP53 pathogenic variants, patients
Author NameAffiliation
Douglas S HawkinsSeattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington
David M ParhamChildren's Hospital Los Angeles and Keck School of Medicine, University of Southern California
David M ParhamChildren's Hospital Los Angeles and Keck School of Medicine, University of Southern California
David MalkinThe Hospital for Sick Children, University of Toronto
David MalkinThe Hospital for Sick Children, University of Toronto
Sharon E PlonTexas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine
Sharon E PlonBaylor College of Medicine
Sharon E PlonBaylor College of Medicine
Aniko SaboBaylor College of Medicine
  • 1 - 9

Datasets

Release 1.2